JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4126
LSI Industries
LYTS
$792M
| $1.68M | ﹤0.01% |
86,550
+57,989
| +203% | +$1.08M |
2020 Q2
18 quarters
|
|
4127
Financial Institutions
FISI
$788M
| $1.68M | ﹤0.01% |
61,484
+43,376
| +240% | +$1.14M |
2013 Q2
46 quarters
|
|
4128
Fidelity MSCI Materials Index ETF
FMAT
$573M
| $1.67M | ﹤0.01% |
34,710
+7,772
| +29% | +$410K |
2022 Q4
8 quarters
|
|
4129
Bridgewater Bancshares
BWB
$577M
| $1.67M | ﹤0.01% |
123,417
+92,855
| +304% | +$1.37M |
2018 Q1
27 quarters
|
|
4130
PUT
American Eagle Outfitters
AEO
$2.97B
| $1.67M | ﹤0.01% |
100,000
| – | – |
2024 Q3
1 quarter
|
|
4131
Nabors Industries
NBR
$1.21B
| $1.67M | ﹤0.01% |
29,147
-19,546
| -40% | -$1.39M |
2013 Q2
46 quarters
|
|
4132
State Street SPDR S&P 500 Fossil Fuel Reserves Free ETF
SPYX
$2.86B
| $1.67M | ﹤0.01% |
34,601
-252
| -0.7% | -$12.2K |
2021 Q1
15 quarters
|
|
4133
iShares Russell 2000 BuyWrite ETF
IWMW
$57.2M
| $1.66M | ﹤0.01% |
37,655
| – | – |
2024 Q1
3 quarters
|
|
4134
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.29B
| $1.66M | ﹤0.01% |
1,388
+271
| +24% | +$334K |
2021 Q4
12 quarters
|
|
4135
Cadeler
CDLR
$2.14B
| $1.65M | ﹤0.01% |
73,958
+2,787
| +4% | +$70.2K |
2023 Q4
4 quarters
|
|
4136
Shore Bancshares
SHBI
$768M
| $1.65M | ﹤0.01% |
104,174
+83,096
| +394% | +$1.29M |
2021 Q4
12 quarters
|
|
4137
Schwab US REIT ETF
SCHH
$10.5B
| $1.64M | ﹤0.01% |
78,093
+1,810
| +2% | +$40.5K |
2017 Q4
28 quarters
|
|
4138
Zymeworks
ZYME
$1.8B
| $1.64M | ﹤0.01% |
111,983
+72,703
| +185% | +$1.02M |
2020 Q4
16 quarters
|
|
4139
Invesco Dividend Achievers ETF
PFM
$775M
| $1.64M | ﹤0.01% |
35,708
-1,090
| -3% | -$51.1K |
2022 Q2
10 quarters
|
|
4140
JPMorgan BetaBuilders USD Investment Grade Corporate Bond ETF
BBCB
$50.3M
| $1.63M | ﹤0.01% |
36,423
-42,992
| -54% | -$1.96M |
2018 Q4
24 quarters
|
|
|
MAGN
4141
Magnera Corp
MAGN
$415M
| $1.63M | ﹤0.01% |
89,680
+44,283
| +98% | +$906K |
2013 Q2
46 quarters
|
|
4142
Build-A-Bear
BBW
$315M
| $1.63M | ﹤0.01% |
35,363
+10,428
| +42% | +$405K |
2022 Q2
10 quarters
|
|
4143
Arrow Financial
AROW
$700M
| $1.62M | ﹤0.01% |
56,571
+37,869
| +202% | +$1.15M |
2016 Q4
32 quarters
|
|
4144
Xometry
XMTR
$5.88B
| $1.62M | ﹤0.01% |
38,065
-72,641
| -66% | -$2.05M |
2021 Q2
14 quarters
|
|
4145
Backblaze
BLZE
$889M
| $1.62M | ﹤0.01% |
269,074
+143,754
| +115% | +$976K |
2023 Q1
7 quarters
|
|
4146
Fidelity MSCI Energy Index ETF
FENY
$2.1B
| $1.62M | ﹤0.01% |
67,939
+6,121
| +10% | +$153K |
2022 Q1
11 quarters
|
|
|
ONIT
4147
Onity Group
ONIT
$228M
| $1.62M | ﹤0.01% |
52,723
+35,468
| +206% | +$1.1M |
2023 Q1
7 quarters
|
|
4148
Ocular Therapeutix
OCUL
$1.53B
| $1.62M | ﹤0.01% |
189,295
+104,650
| +124% | +$1.02M |
2017 Q1
31 quarters
|
|
4149
Acumen Pharmaceuticals
ABOS
$148M
| $1.61M | ﹤0.01% |
937,908
+874,842
| +1,387% | +$2.11M |
2021 Q3
13 quarters
|
|
4150
VanEck Biotech ETF
BBH
$476M
| $1.61M | ﹤0.01% |
10,261
-1,811
| -15% | -$305K |
2022 Q2
10 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.